AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
David Abrams' Abrams Capital Management Portfolio Q2 2025 Update: Essential Holdings and Portfolio Changes
ByAinvest
Tuesday, Aug 12, 2025 9:32 pm ET1min read
David Abrams' Abrams Capital Management portfolio has been analyzed in a series of articles. The latest update is based on Abrams' regulatory 13F Form filed on 08/08/2025. The analysis covers the changes made to Abrams' portfolio on a quarterly basis.
David Abrams' Abrams Capital Management portfolio, as detailed in the latest 13F Form filed on 08/08/2025, shows notable changes in the second quarter of 2025. The portfolio value increased from $5.64 billion to $6.11 billion, with 12 holdings remaining steady. The top three stakes account for approximately 67% of the portfolio, while the top five holdings make up about 80%.Key changes include the addition of Circle Internet Group (CRCL), a small 0.82% stake established during the quarter, following its IPO on June 5th. The stock has since traded between $64 and $299, currently at $163. Cantaloupe Inc. (CTLP), with a small ~1% position, was sold this quarter at prices between $7.01 and $11.03, following an acquisition by 365 Retail Markets. Loar Holdings (LOAR), the largest position at ~45%, saw a ~14% reduction this quarter at prices between $67 and $100.
Lithia Motors (LAD), currently the second-largest position at ~14%, saw a minor ~2% stake increase during the last quarter. Asbury Automotive (ABG), with an 8% stake, and Somnigroup Intl. (SGI), with a 6.51% stake, also saw increases. Coupang Inc. (CPNG) and Alphabet Inc. (GOOG) experienced significant gains, with CPNG increasing by ~120% and GOOG by ~20% in the previous quarters. Meta Platforms (META) saw a ~30% reduction this quarter at prices between $553 and $741, currently trading at ~$790.
Willis Towers Watson plc (WTW) and U-Haul Holding Company (UHAL) saw minor reductions. Energy Transfer LP (ET) experienced a significant reduction, with the stake decreasing by two-thirds this quarter at prices between $16.83 and $21.45. Nuvation Bio (NUVB), following a merger, remains a small position at 0.12% of the portfolio.
This update reflects Abrams' strategy of maintaining a diversified portfolio with a focus on growth and long-term investments.
References:
[1] https://seekingalpha.com/article/4812861-tracking-david-abrams-abrams-capital-management-portfolio-q2-2025-update
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet